Atlas Trials

Immunogenicity and Safety Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) in Adults Aged 50 Years and Older

Clinical trial NCT00782431 · COMPLETED

Trial details

NCT number
NCT00782431
Sponsor
Alachua Government Services, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Influenza
Start date
2008-11-01
Primary completion
2008-12-01
Enrollment
3208

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.